Health & Safety Industry Today
Immunotherapy Drugs Market size to Reach USD 288.24 Billion by 2031 Driven by Expanding Oncology Applications and Combination Therapy Trends
Immunotherapy Drugs Market Overview
According to Mordor Intelligence, the immunotherapy drugs market size is estimated at USD 173.33 billion in 2026, rising from USD 156.52 billion in 2025 and expected to reach USD 288.24 billion by 2031, growing at a CAGR of 10.74% during the forecast period. This steady expansion highlights the growing role of immune-targeting therapies in modern medicine.
The immunotherapy drugs industry is largely driven by the rising use of checkpoint inhibitors, advancements in T-cell engineering, and the integration of artificial intelligence in drug discovery. These developments are improving treatment precision and reducing development timelines.
Key Trends Shaping the Immunotherapy Drugs Market
Rising Adoption of Checkpoint Inhibitors in Oncology
Checkpoint inhibitors remain central to the immunotherapy drugs market trends, particularly in cancer treatment. These therapies are increasingly used as first-line treatments in solid tumors, supported by strong clinical outcomes. Their ability to enhance immune response against cancer cells continues to expand their role across multiple indications.
Growth in T-Cell Engineering and Cell Therapies
The development of T-cell therapies such as CAR-T and TCR is reshaping the immunotherapy drugs industry. These therapies are moving beyond early-stage trials into broader clinical applications. Continuous research is improving their safety and effectiveness, contributing to the overall immunotherapy drugs market growth.
Integration of Artificial Intelligence in Drug Development
Artificial intelligence is becoming an important tool in the immunotherapy drugs market, helping companies identify targets, design molecules, and predict outcomes more efficiently. This trend is shortening discovery cycles and reducing failure rates, which positively influences the immunotherapy drugs market forecast.
Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/immunotherapy-drugs-market?utm_source=industrytoday
Immunotherapy Drugs Market Segmentation
By Drug Type
- Monoclonal antibodies
- Checkpoint inhibitors
- Cancer vaccines
- Interferons alpha or beta
- Interleukins
- Oncolytic viral therapies
- T-cell therapies including CAR-T, TCR, and TIL
- Cytokines and immunomodulators
- Other drug types
By Therapy Area
- Cancer
- Autoimmune and inflammatory diseases
- Infectious diseases
- Other therapy areas
By End-User
- Hospitals and clinics
- Research laboratories and academic institutes
- Pharmaceutical and biotechnology companies
By Geography
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- South America
Explore Our Full Library of Healthcare Research Report:
https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=industrytoday
Immunotherapy Drugs Market Competitive Landscape
The competitive landscape of the immunotherapy drugs market shows moderate consolidation, with established pharmaceutical companies and emerging biotech firms actively participating.
Key Players in the Immunotherapy Drugs Market
- Amgen Inc.
- Novartis AG
- AbbVie Inc.
- F. Hoffmann-La Roche AG
- GSK PLC
Explore more insights on immunotherapy drugs competitive landscape: https://www.mordorintelligence.com/industry-reports/immunotherapy-drugs-market/companies?utm_source=industrytoday
Conclusion
The future of the immunotherapy drugs market remains promising, supported by continuous advancements in science and increasing clinical adoption. The shift toward personalized medicine, combined with the growing acceptance of immune-based therapies, is expected to sustain long-term demand.
The immunotherapy drugs market forecast indicates that ongoing research in areas such as gene editing and next-generation cell therapies will further expand treatment possibilities. At the same time, improvements in manufacturing and regulatory processes will help make these therapies more accessible.
Get detailed insights on the immunotherapy drugs market:
Industry Related Reports
Iron Deficiency Anemia Therapy Market:
Allergy Treatment Market size:
Osteoarthritis Treatment Market share:
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
For any inquiries or to access the full report, please contact:
https://www.mordorintelligence.com/
Share on Social Media
Other Industry News
Ready to start publishing
Sign Up today!
